← All Nevro CORP filings

Nevro CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NVRO
Nevro CORP
DEFA14A: Globus Medical to Acquire Nevro Corp. in $3 Billion Deal
Nevro Corp. and Globus Medical have announced a definitive agreement for Globus Medical to acquire Nevro, creating a combined medical technology leader with approximately $3 billion in annual sales.
NVRO
Nevro CORP
DEFA14A: Globus Medical to Acquire Nevro Corp. for $5.85 Per Share in All-Cash Deal
Globus Medical will acquire Nevro in an all-cash transaction for $5.85 per share, aiming to expand treatment options for patients and create a combined medical technology leader.
NVRO
Nevro CORP
DEFA14A: Nevro Corp. Sets Date for 2024 Annual Stockholder Meeting
Nevro Corp. will hold its annual stockholder meeting virtually on May 23, 2024, to vote on director elections, auditor ratification, and executive compensation.
NVRO
Nevro CORP
DEF 14A: Nevro Corp. Announces Details for 2024 Annual Stockholders Meeting
Nevro Corp. will hold its annual stockholders meeting online on May 23, 2024, to vote on director elections, auditor ratification, and executive compensation.